Details

---

Manufacturer:

AstraZeneca UK Limited

Registration Number:

MAL19930010AZ

Contents

Tamoxifen Citrate (equivalent to 20 mg tamoxifen)
 

Indications:

• Treatment of breast cancer in both premenopausal and postmenopausal women

• Adjuvant therapy following surgery and radiation in early-stage breast cancer

• Management of ductal carcinoma in situ (DCIS)

• Prevention of breast cancer in high-risk women
   

Instructions:

• Administration:

  • Take orally with or without food

  • Swallow tablets whole; do not chew or crush

  • Maintain a consistent daily dosing schedule

• Dosage:

  • 20 mg to 40 mg daily, either as a single dose or divided into two doses

  • For early-stage breast cancer, treatment duration is typically 5 years